Clinical Utility of 18F-FDG PET/CT Concurrent with 131I Therapy in Intermediate–to–High-Risk Patients with Differentiated Thyroid Cancer: Dual-Center Experience with 286 Patients-Reference-Cited by-同舟云学术

Clinical Utility of 18F-FDG PET/CT Concurrent with 131I Therapy in Intermediate–to–High-Risk Patients with Differentiated Thyroid Cancer: Dual-Center Experience with 286 Patients

Published:2013-06-27 Issue:8 Volume:54 Page:1230-1236
ISSN:0161-5505
Container-title:Journal of Nuclear Medicine
language:en
Short-container-title:J Nucl Med

Author:

Lee Jeong Won,Lee Sang Mi,Lee Dae Ho,Kim Yeo Joo

Publisher

Society of Nuclear Medicine

Subject

Radiology Nuclear Medicine and imaging

Reference37 articles.

1. Revised American Thyroid Association Management Guidelines for Patients with Thyroid Nodules and Differentiated Thyroid Cancer

2. Long-term impact of initial surgical and medical therapy on papillary and follicular thyroid cancer

3. A Systematic Review and Metaanalysis of the Effectiveness of Radioactive Iodine Remnant Ablation for Well-Differentiated Thyroid Cancer

4. Prognostic Factors Associated with the Survival of Patients Developing Loco-Regional Recurrences of Differentiated Thyroid Carcinomas

5. Therapeutic impact of 18FDG-PET/CT in the management of iodine-negative recurrence of differentiated thyroid carcinoma

Cited by 52 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Positron Emission Tomography/Computed Tomography in Thyroid Cancer;PET Clinics;2024-04

2. How [18F]FDG-PET/CT Affects the Management of Patients with Differentiated Thyroid Carcinoma in Clinical Routines;Cancers;2024-01-30

3. Thyroid Cancer;Neuroendocrine Tumours;2024

4. Current practice in intermediate risk differentiated thyroid cancer – a review;Reviews in Endocrine and Metabolic Disorders;2023-11-23

5. Tumor Microenvironment Features as Predictive Biomarkers in Metastatic Differentiated Thyroid Cancer and Their Relationship With 18F-Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography (18F-FDG PET/CT) Metabolic Parameters;Cureus;2023-09-05